ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 101 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $105,899 | -11.7% | 52,167 | 0.0% | 0.00% | – |
| Q2 2023 | $119,984 | -6.1% | 52,167 | +23.7% | 0.00% | – |
| Q1 2023 | $127,748 | +30.0% | 42,161 | 0.0% | 0.00% | – |
| Q4 2022 | $98,235 | +22.5% | 42,161 | +0.4% | 0.00% | – |
| Q3 2022 | $80,207 | -32.3% | 41,993 | -3.9% | 0.00% | – |
| Q2 2022 | $118,462 | +10.2% | 43,713 | +21.1% | 0.00% | – |
| Q1 2022 | $107,530 | -35.6% | 36,084 | -16.1% | 0.00% | – |
| Q4 2021 | $167,000 | -15.7% | 42,985 | -7.0% | 0.00% | – |
| Q3 2021 | $198,000 | +33.8% | 46,204 | -5.4% | 0.00% | – |
| Q2 2021 | $148,000 | +59.1% | 48,865 | +86.6% | 0.00% | – |
| Q1 2019 | $93,000 | +121.4% | 26,188 | +140.4% | 0.00% | – |
| Q4 2018 | $42,000 | -81.2% | 10,892 | -53.7% | 0.00% | – |
| Q3 2018 | $223,000 | +2.3% | 23,506 | -21.4% | 0.00% | – |
| Q2 2018 | $218,000 | – | 29,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |